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Endophytic actinomycetes were isolated from the root of Sophora flavescens. These 
isolated actinomycetes were identified by morphology characterization and analysis of 
partial 16S rDNA sequences. Micromonospora sp. and Actinomadura sp. isolated as 
endophytic actinomycetes were cultivated in liquid medium to analyze their metabolites. 
The results revealed that Micromonospora sp. and Actinomadura sp. produce k4610422 
(1), and madurastatin A1 acetone adduct (2) and (‒)-tetrangomycin (3), respectively.  
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Actinomycetes are Gram-positive bacteria known 
to constitute a large part of the rhizosphere 
microbiota. Some actinomycetes are found in 
plants as endophytic, and thought to influence 
plant growth and protect plant roots against 
pathogenic fungi.1) Furthermore, actinomycetes 
are well known as producers of various kinds of 
metabolites, such as antibiotics, anticancer and 
immunosuppression agents. Therefore, 
actinomycetes including endophytic have been 
said to be promising producers of medicinal 
sources for a long time. Sophora flavescens Aiton 
belongs to Leguminosae. The herbal drug 
SOPHORE RADIX, derived from the dry roots of 
S. flavescens, is a common traditional medicine 
used to combat gastric disturbance, and for its 
antifebrile, anodyne and anthelmintic activities.2) 
The major constituents of SOPHORAE RADIX 
are matrine alkaloids and a series of prenylated 
and lavandulated flavonoids.3, 4) On considering 
the quality control of traditional natural medicines, 
we should focus on their cultivated place, season, 
and endophytic microbes. However, no 
actinomycetes have been isolated from the root of 
S. flavescens so far.   
Therefore, we describe the isolation of endophytic 
actinomycetes from the root of S. flavescens and 
their metabolites in this report. This is the first 
report on the isolation and identification of 
endophytic actinomycetes in S. flavescens. The 
studies focusing on the root of S. flavescens used 
as a traditional natural medicine and considering 
the quality control of natural medicines are few. 
Five (M1-5) and eight (O1-8) actinomycetes 
strains were isolated from S. flavescens grown (or 
collected) at Moroyama, and Ogose, in Saitama 
Pref., respectively. These isolates were simply 
identified by determination of 16S rDNA 
sequences. Although the epidermis of the root was 
removed before being crushed into small pieces 
for the isolation of actinomycetes, we could not 
strictly distinguish if these isolates were 
endophytic or soil actinomycetes. However, some 
of isolates were found to be closely related to 
actinomycetes previously isolated in 
Leguminosae plants as endophytic. Though 
isolate M4 seemed to belong to genus 
Micromonospora, partial 16S rDNA of M4 was 
homologous to soil-isolated Micromonospora 
strains. Isolate M6 was also found to be related to 
Micromonospora strains which were isolated 
from Leguminosae plants.5) Thus it seemed that 
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we could successfully access endophytic 
actinomycetes of S. flavescens. On the other hand, 
O8 seemed to belong to genus Actinomadura 
according to the same method as described above. 
In this research, we have focused on isolates M4 
and O8 strains and tried to determine their 
metabolites. Strain M4 was cultivated with 8 L of 
YMGS at 29 C for 6 days in a 14 L jar fermenter. 
Strain O8 was cultivated with 7 L of YMG at 28 
C for 6 days and with 7.5 L of GLY at 28 C for 
10 days separately. The fermentation culture broth 
of M4 was extracted with acetone and filtered to 
remove the insoluble portion. The resultant filtrate 
was extracted with n-BuOH to give an n-BuOH 
soluble portion. After the evaporation of organic 
solvent with a rotary evaporator, the residue was 
loaded on Diaion HP-20 (H2O 50% aqueous 
MeOH MeOH acetone). The methanolic 
elute was further purified with Sephadex LH-20, a 
silica gel open column and HPLC purification to 
afford k4610422 (1) (0.9 mg). The fermentation 
crude broth of O8 was partitioned with EtOAc to 
give a corresponding soluble portion. The 
EtOAc-soluble portion was purified by liquid 
chromatography to give madurastatin A1 acetone 
adduct (2) (19.7 mg) and (‒)-tetrangomycin (3) 
(5.8 mg) (Fig. 1). The structures of these isolates 
were confirmed with spectroscopic data such as 
NMR and MS. Finally, comparisons of spectral 
data were conducted with literature values. The 
first of the three isolated compounds is 
diterpenoide k4610422, which acts as a 
5α-reductase inhibitor.6) The second compound is 
an acetone adduct of madurastatin A1. 
Madurastatin A1 is known as a siderophore and 
plays an important role in the uptake of Fe3+ from 
the surrounding environment.7) The last is 
(‒)-tetrangomycin, which is known as an 
anti-methicillin resistant Staphylococcus aureus 
agent, including antioxidant and anticancer 
agents.8-10) Since endophytic actinomycetes 
potentially show ability to introduce biological 
metabolites, endophytic actinomycetes living in a 
medicinal plant may influence metabolite 
production of its medicinal plant. Considering the 
quality control of natural medicines, the existence 
of endophytic actinomycetes cannot be ignored 
any longer.  
 
Fig. 1. Structures of Compound 1-3 from 
endophytic actinomycetes isolated from the 
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